Kay Chandler, MD
Obstetrics & Gynecology · Little Rock, ARNPI 1922075746
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,142 of the $4,649 with a category attached, or 67.6%. 30 manufacturers reported payments, led by Minerva Surgical, Inc at 34.4% of the total. Reporting peaked in 2019 at $1,847 and has fallen 86.5% since, to $249 in 2025.
Across 174 payments — averaging $26.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Minerva Surgical, Inc$2K
- AbbVie$653
- Astellas Pharma US Inc$418
- Bayer$311
- Aspira Women's Health Inc$181
- Exeltis, USA Inc.$164
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$1,50032%
- Food & beverage$3,14268%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Minerva Surgical, Inc | 4 | $1,601 |
| AbbVie(2 entities) | 42 | $653 |
| Astellas Pharma US Inc | 22 | $418 |
| Bayer | 17 | $311 |
| Aspira Women's Health Inc | 2 | $181 |
| Exeltis, USA Inc. | 9 | $164 |
| Mayne Pharma Commercial LLC | 12 | $145 |
| Therapeuticsmd, Inc. | 9 | $131 |
| Organon | 12 | $130 |
| Davol Inc. | 3 | $127 |
| Medtronic | 1 | $118 |
| Pfizer | 7 | $105 |
| Shield Therapeutics Inc | 5 | $97 |
| Merck | 4 | $56 |
| Biogen | 2 | $44 |
| Avion Pharmaceuticals | 3 | $43 |
| Mylan Pharmaceuticals Inc. | 3 | $43 |
| Hologic Sales And Service, LLC | 3 | $42 |
| Johnson & Johnson | 1 | $38 |
| Evofem Biosciences, Inc. | 2 | $29 |
| Scynexis, Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| BD | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Meditrina | 1 | $16 |
| Lupin Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Myovant Sciences Inc. | 1 | $12 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endometrial Ablation System (Device)$1,500
- Signia$118
- Veozah$112
- OVA1$106
How this compares
$4,649 in reported general payments places this provider in the 80th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 342 | $11,404 |
| Estradiol | 289 | $5,291 |
| Liothyronine Sodium | 156 | $4,502 |
| SynthroidLevothyroxine Sodium | 43 | $2,282 |
| Np ThyroidThyroid,pork | 33 | $1,468 |
| Estradiol (Once Weekly)Estradiol | 19 | $1,354 |
| DottiEstradiol | 17 | $983 |
| Estradiol (Twice Weekly)Estradiol | 14 | $975 |
| Clobetasol Propionate | 20 | $951 |
| ValacyclovirValacyclovir Hcl | 34 | $914 |
| Levothyroxine Sodium | 90 | $422 |
| Spironolactone | 49 | $368 |
| Trazodone Hcl | 26 | $186 |
| Nystatin | 11 | $127 |
| Dicyclomine Hcl | 11 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $653 | $2,28243 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $15 | $1,46833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 272 obstetrics & gynecology providers in Arkansas.
Other obstetrics & gynecology in Little Rock
- Michael CopeLittle Rock$147K
- David ShenkerLittle Rock$28K
- Julia GoodwinLittle Rock$16K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Nirvana ManningLittle Rock$10K
- Sharai AmayaLittle Rock$9K
- Emily WilliamsLittle Rock$9K
- Shelly GibbsLittle Rock$8K
- Stacy Ulmer-PinterLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.